Nocardia cyriacigeorgica Infection in a COPD Patient
Abstract
BACKGROUND: Pulmonary infections caused by Nocardia spp. exhibit diverse clinical manifestations. However, the clinical manifestations and imaging examinations of the disease lack specificity, leading to an increased misdiagnosis rate. Therefore, the etiological diagnosis is crucial for the confirmation of this disease. Nocardia cyriacige-orgica is an aerobic, weak acid-fast, Gram-positive opportunistic pathogen characterized by slow growth.
METHODS: In March 2024, a sputum specimen was sent for examination by the Department of Respiratory and Critical Care Medicine. The appearance was yellow purulent sputum, and no obvious "sulfur particles" were found. Gram staining of sputum revealed numerous Gram-positive bacilli with 90° branching and even tangled filamentous forms, and weak acid-fast staining was positive. Under aerobic conditions at a constant temperature of 37℃, we observed slow-growing colonies that were white, dry, and wrinkled on blood agar.
RESULTS: We used MALDI-TOF MS for identification, and by comparing the mass spectrum peaks of the isolate with the known mass spectrum peaks in the database (MS-IVD database version 3.0), the result was Nocardia cyriacigeorgica with 99.9% confidence. The patient was started on empiric antibiotic therapy with piperacillintazobactam (4.5 g, q 8 hour), along with supportive measures such as nebulized treatments, cough suppressants, bronchodilators, oxygen therapy, and gastric acid suppression. Due to the patient's acute…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Impact of antibiotics on the human microbiome and consequences for host health
- Antibiotics in the clinical pipeline in October 2019
- The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan
- Research Communications of the 32nd ECVIM-CA Online Congress
- Singlet-Oxygen Therapy. Scientific And Methodological Materials
- Artificial Intelligence in Pharmacovigilance
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.